We have several projects co-financed by the European Union under the Innovative Economy Operational Program. These are projects in the areas of medical biotechnology: regenerative therapy and targeted therapy. Our activities are aimed at producing products for the needs of research laboratories. Additionally, in the long term, we strive to develop innovative therapies.
‘Introduction to the biomedical market of a broad spectrum of stem cells’
contract number: UDA-POIG.01.04.00-10-011 / 11-00 (Project value 3,866,880.00 PLN)
‘Innovative living biodegradable dressing for chronic wounds and ulcers’
contract number: UDA-POIG.01.04.00-10-020 / 10-00 (Project value 9,363,920.00 PLN)
along with the investment project
‘Introduction to the market of an innovative biodegradable dressing’
contract number: UDA-POIG.04.06.00-10-024 / 12-00 (Project value 29,017,422.00 PLN)
‘Development of anti-cancer targeted therapy’
contract number: UDA-POIG.01.04.00-10-037 / 11-00 (Project value 18,675,700.00 PLN)
‘Innovative platform for assessing the effectiveness and toxicity of anti-cancer drugs’
contract number: UDA-POIG.01.04.00-10-012 / 11-00 (Project value 4,821,230.00 PLN)
